TranS1 Inc. Announces Participation in Two Healthcare Conferences

TranS1 Inc. Announces Participation in Two Healthcare Conferences

WILMINGTON, N.C., Feb. 21, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON)
announced today that it will participate in two healthcare conferences in
February and March, 2013.

Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive
Vice President and Chief Financial Officer, are scheduled to attend the Lazard
Snowbird Medical Technology Conference on Thursday, February 28, 2013, in
Snowbird, UT and present at the 2013 Cowen & Company Healthcare Conference in
Boston, MA on Wednesday, March 6, 2013 at 10:00 am ET.

Institutional investors that wish to request a meeting with TranS1 should
contact Lazard Capital Markets or Cowen & Company.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and
marketing products to treat degenerative conditions of the spine affecting the
lumbar region. TranS1 currently markets the AxiaLIF® family of products for
single and two level lumbar fusion, the VEO^TM direct lateral access and
interbody fusion system and the Vectre^TM posterior fixation system for lumbar
fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is
headquartered in Wilmington, North Carolina. For more information, visit
www.trans1.com.

CONTACT: Investors:
         TranS1 Inc.
         Joseph P. Slattery, 910-332-1700
         Executive Vice-President and Chief Financial Officer
        
         Westwicke Partners
         Mark Klausner, 443-213-0501
         trans1@westwicke.com